Stewart BH - Search Results

1

Atorvastatin coadministration may increase digoxin concentrations by inhibition of intestinal P-glycoprotein-mediated secretion.

Boyd RA, Stern RH, Stewart BH, Wu X, Reyner EL, Zegarac EA, Randinitis EJ, Whitfield L. Boyd RA, et al. Among authors: stewart bh. J Clin Pharmacol. 2000 Jan;40(1):91-8. doi: 10.1177/00912700022008612. J Clin Pharmacol. 2000. PMID: 10631627 Clinical Trial.

2

Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.

Wu X, Whitfield LR, Stewart BH. Wu X, et al. Among authors: stewart bh. Pharm Res. 2000 Feb;17(2):209-15. doi: 10.1023/a:1007525616017. Pharm Res. 2000. PMID: 10751037

3

Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans.

Stewart BH, Chan OH, Lu RH, Reyner EL, Schmid HL, Hamilton HW, Steinbaugh BA, Taylor MD. Stewart BH, et al. Pharm Res. 1995 May;12(5):693-9. doi: 10.1023/a:1016207525186. Pharm Res. 1995. PMID: 7479555

4

Transport of pregabalin in rat intestine and Caco-2 monolayers.

Jezyk N, Li C, Stewart BH, Wu X, Bockbrader HN, Fleisher D. Jezyk N, et al. Among authors: stewart bh. Pharm Res. 1999 Apr;16(4):519-26. doi: 10.1023/a:1018866928335. Pharm Res. 1999. PMID: 10227706 Free article.

5

In vitro assessment of oral delivery for hexapeptide endothelin antagonists.

Stewart BH, Reyner EL, Tse E, Hayes RN, Werness S, He JX, Cody WL, Doherty AM. Stewart BH, et al. Life Sci. 1996;58(12):971-82. doi: 10.1016/0024-3205(96)00045-8. Life Sci. 1996. PMID: 8786709

6

Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.

Cody WL, He JX, Reily MD, Haleen SJ, Walker DM, Reyner EL, Stewart BH, Doherty AM. Cody WL, et al. Among authors: stewart bh. J Med Chem. 1997 Jul 4;40(14):2228-40. doi: 10.1021/jm970161m. J Med Chem. 1997. PMID: 9216842

7

Nonpeptidic HIV protease inhibitors: 4-hydroxy-pyran-2-one inhibitors with functional tethers to P1 phenyl ring to reach S3 pocket of the enzyme.

Vara Prasad J, Tummino PJ, Ferguson D, Saunders J, Vander Roest S, McQuade TJ, Heldsinger A, Reyner EL, Stewart BH, Guttendorf RJ, Para KS, Lunney EA, Gracheck SJ, Domagala JM. Vara Prasad J, et al. Among authors: stewart bh. Biochem Biophys Res Commun. 1996 Apr 25;221(3):815-20. doi: 10.1006/bbrc.1996.0679. Biochem Biophys Res Commun. 1996. PMID: 8630044

8

Improved intestinal transport of PD 158473, an N-methyl-D-aspartate (NMDA) antagonist, by involvement of multiple transporters.

Oh DM, Han HK, Williamson RM, Bigge CF, Amidon GL, Stewart BH, Surendran N. Oh DM, et al. Among authors: stewart bh. J Pharm Sci. 2002 Dec;91(12):2579-87. doi: 10.1002/jps.10241. J Pharm Sci. 2002. PMID: 12434401

9

CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs.

Han HK, Rhie JK, Oh DM, Saito G, Hsu CP, Stewart BH, Amidon GL. Han HK, et al. Among authors: stewart bh. J Pharm Sci. 1999 Mar;88(3):347-50. doi: 10.1021/js980132e. J Pharm Sci. 1999. PMID: 10052994 Free article.

10

Transport properties are not altered across Caco-2 cells with heightened TEER despite underlying physiological and ultrastructural changes.

Lu S, Gough AW, Bobrowski WF, Stewart BH. Lu S, et al. Among authors: stewart bh. J Pharm Sci. 1996 Mar;85(3):270-3. doi: 10.1021/js950269u. J Pharm Sci. 1996. PMID: 8699327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page